Crisnatol, formerly known as BWA770U, is a potent and selective DNA intercalator with potential anticancer activity. Crisnatol entered into phase I and II clinical trials. It was discontinued now. References: Villalona-Calero MA, Petit T, Kuhn J, Cobb P, Kraynak M, Eckhardt SG, Drengler R, Simmons C, Santabarbara P, Von Hoff DD, Rowinsky EK. A phase I and pharmacological study of protracted infusions of crisnatol mesylate in patients with solid malignancies. Clin Cancer Res. 1999 Nov;5(11):3369-78. PubMed PMID: 10589747.

纯度：≥98%

CAS：96389-69-4